IRIS UniCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.368
EU - Europa 5.186
AS - Asia 4.171
SA - Sud America 633
OC - Oceania 180
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.094
DE - Germania 1.736
SG - Singapore 1.593
CN - Cina 1.276
IT - Italia 741
SE - Svezia 683
BR - Brasile 505
VN - Vietnam 426
FR - Francia 344
GB - Regno Unito 331
UA - Ucraina 298
PL - Polonia 264
IN - India 204
CA - Canada 182
FI - Finlandia 178
IE - Irlanda 160
AU - Australia 155
ID - Indonesia 115
JP - Giappone 85
TR - Turchia 74
RU - Federazione Russa 73
HK - Hong Kong 70
NL - Olanda 65
BD - Bangladesh 57
MX - Messico 53
AR - Argentina 40
AT - Austria 38
ES - Italia 38
ZA - Sudafrica 34
IQ - Iraq 33
CH - Svizzera 27
BE - Belgio 26
IR - Iran 26
PK - Pakistan 26
RO - Romania 25
KR - Corea 24
CI - Costa d'Avorio 23
NZ - Nuova Zelanda 23
CZ - Repubblica Ceca 19
CO - Colombia 17
EG - Egitto 17
VE - Venezuela 17
GR - Grecia 16
IL - Israele 16
MY - Malesia 16
SA - Arabia Saudita 16
AE - Emirati Arabi Uniti 15
EC - Ecuador 15
HU - Ungheria 15
DZ - Algeria 14
LT - Lituania 12
MA - Marocco 12
PY - Paraguay 12
BG - Bulgaria 11
CL - Cile 11
PT - Portogallo 11
UZ - Uzbekistan 11
KE - Kenya 10
NO - Norvegia 10
PH - Filippine 10
SK - Slovacchia (Repubblica Slovacca) 10
TH - Thailandia 10
DK - Danimarca 9
LB - Libano 9
HN - Honduras 7
HR - Croazia 7
JM - Giamaica 7
JO - Giordania 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
GE - Georgia 6
NP - Nepal 6
PE - Perù 6
RS - Serbia 6
TN - Tunisia 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
KG - Kirghizistan 5
LV - Lettonia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
CG - Congo 4
MK - Macedonia 4
OM - Oman 4
PS - Palestinian Territory 4
SI - Slovenia 4
SN - Senegal 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
LY - Libia 3
ME - Montenegro 3
PR - Porto Rico 3
BB - Barbados 2
CR - Costa Rica 2
Totale 17.650
Salva come PNG Salva come JPEG
Città #
Singapore 938
Chandler 638
Ashburn 606
San Jose 459
Beijing 308
Jacksonville 223
Warsaw 222
Munich 193
Houston 169
Los Angeles 167
Dublin 151
New York 151
Nanjing 150
Dearborn 142
San Mateo 140
Milan 135
Woodbridge 133
Ann Arbor 132
Fairfield 131
Ho Chi Minh City 129
Hanoi 120
Rome 118
Wilmington 113
Hangzhou 105
Nürnberg 95
Jakarta 94
Redwood City 93
Seattle 93
Helsinki 92
Chicago 91
The Dalles 86
Dallas 84
Lauterbourg 83
Cambridge 76
Tokyo 69
Bremen 67
Hefei 67
Hong Kong 65
Boston 59
Nanchang 59
Frankfurt am Main 58
Council Bluffs 56
Cattolica 52
Lawrence 52
Moscow 52
Orem 51
Buffalo 48
São Paulo 48
Santa Clara 42
Brooklyn 41
London 40
Izmir 37
Marseille 37
Sydney 36
Guangzhou 35
Toronto 35
Kunming 33
San Francisco 33
Shanghai 33
Boardman 32
Portland 32
Phoenix 30
Atlanta 29
Denver 29
Lancaster 29
Haiphong 28
Melbourne 27
Montreal 26
Brisbane 24
Hyderabad 24
Shenyang 24
Abidjan 23
Chennai 23
Princeton 23
Adelaide 22
Tianjin 22
Brussels 21
Poplar 21
Johannesburg 20
Kent 20
Changsha 19
Leawood 19
Nuremberg 19
Amsterdam 18
Auburn Hills 18
Da Nang 18
Hebei 18
Redmond 18
Fremont 17
Jiaxing 17
Mexico City 17
Philadelphia 17
Mumbai 16
San Diego 16
Baghdad 15
Manchester 15
Mountain View 15
University Park 15
Zhengzhou 15
Augusta 14
Totale 8.730
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 3.462
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 342
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 329
DNMT1-interacting RNAs block gene-specific DNA methylation 291
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 269
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 242
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 241
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 240
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 239
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 234
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 234
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 233
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 222
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 215
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 195
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 193
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 191
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 190
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 184
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 183
Epigenetic changes in therapy-related MDS/AML 181
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 181
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 175
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 172
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 170
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 166
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 160
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 159
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 158
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 156
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 156
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 156
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 154
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 153
PU.1 and CEBPA expression in acute myeloid leukemia. 153
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 153
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 152
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 152
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 150
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 150
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 148
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 148
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 144
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 144
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 141
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 140
Aggiornamenti di Diagnostica Molecolare in Ematologia 139
Mantle cell lymphoma relapsing at the lymphedematous arm 138
Outcome of therapy-related myeloid neoplasms treated with azacitidine 137
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 137
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 135
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 135
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 134
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 133
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 132
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 127
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 126
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 123
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 120
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 119
CAR-T Cell Therapy for Follicular Lymphomas 109
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 104
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 101
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 88
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 86
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study 85
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 81
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 78
Absence of structural mutations of the BAK gene in B cell lymphomas 77
Case of metastatic melanoma in bone marrow smear 76
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 75
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 37
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 30
Totale 17.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022871 103 80 13 31 65 36 26 133 51 70 122 141
2022/20231.867 259 261 128 319 114 216 95 141 175 39 74 46
2023/20241.669 54 256 71 92 114 193 81 109 81 151 226 241
2024/20252.804 297 204 269 144 224 113 210 149 325 224 357 288
2025/20265.393 646 223 268 489 892 336 981 364 426 367 301 100
Totale 17.864